Jennifer J. Cory, MA2, CRA

Director of Strategy and Operations

Ms Cory has over 20 years of experience in research administration in the academic environment, having held positions in pre-award, business operations, and post-award management and compliance. She has extensive experience building teams and programs, focusing on adaptability and efficiency by implementing processes to facilitate workflow and communication. 

She is responsible for strategy, program management and coordination, overseeing finance, administration, business development and compliance for the Center. 

View Jennifer Cory's profile >>


Yanfeng “Alex” Wang, PhD

Director of Business Development

Dr Wang leads business development for the CDCM and is the key liaison to industry partners. He spent several years at the University of Maryland where he was the Director of the Maryland International Incubator, prior to which he worked in biotech and in consulting for Ernst & Young. He has extensive experience working with academic and private sector partners in the development of programs, including the provision of project management and financial planning support. Alex earned his MBA from the University of Notre Dame and his PhD in Cell and Molecular Biology from the University of Pennsylvania. 

View Alex Wang's profile >>

Rhonda Perriman, PhD

Research Development Manager

Rhonda Perriman is the Grants Manager and Scientific Editor for the CDCM. She completed her PhD. at Australian National University and her postdoctoral training as an American Cancer Society fellow at the University of California, Santa Cruz (UCSC). Following this training, she worked as a Senior Research Scientist at UCSC studying structure-function relationships within the multi-subunit RNA-protein enzyme (spliceosome) responsible for pre-mRNA splicing in eukaryotes. Her research provided substantial insights into the mechanistic details of novel spliceosomal RNA rearrangements that are required for accurate pre-mRNA splicing, and identified key protein co-factors that aid these. She is proficient in genetics, genomics, biochemistry, and molecular biology. Currently she leads the preparation of scientific proposals, grant applications and original manuscripts being submitted by faculty in the CDCM and Stem Cell Transplant and Regenerative Medicine. She also assists in the preparation of pre- and IND submissions to the FDA for approval of Clinical Trials.

Rowel Padilla

Finance Manager

Rowel supports the CDCM’s financial management, coordinates payments, and supports research operations. He has various finance roles at Stanford but is also skilled in facilities management, information security, and was active duty US Army for over 10 years.

Ginger Exley

Executive Assistant and Program Coordinator

Ginger Exley is an expert administrator and program coordinator with over five year’s of experience at Stanford. She also worked in the private sector for over 15 years, supporting executives and senior leadership. She supports the leadership of the CDCM, their labs, and our operations.


Nick Yu

Communications Manager

Nick is a graduate of UC Berkeley, where he studied nutritional science and discovered a passion for healthcare through both his coursework and his experience in biology, chemistry, and physiology labs. He supports the CDCM as the communications manager, where he regularly updates their website and social media channels, and assists with marketing activities and event planning as well. 

Research Team

Abinaya Nathan, PhD

Senior Discovery Stage Project Manager

Abinaya Nathan is currently the Discovery Stage Project Manager for CDCM. She completed her PhD followed by a postdoctoral scientist position in an aging institute in Germany. She worked at Stanford as a Research Scientist working on pulmonary arterial hypertension and its impact on cardiovascular disease. During that time, she was a key player in the academic setting by performing and planning experiments of in vivo and in vitro biochemical/ cellular assays leading to a number of scientific publications. Alongside, she was also responsible in managing the lab in both, lab supply replenishment as well as supervision of high school and undergraduate students. Her current role is to plan, coordinate and manage investigator-initiated translational research projects of cell and gene therapies from its development to filing and submission of the IND. 

View Abinaya Nathan's profile >>

Manasvi Marathe, BDS, MPH

Discovery Stage Project Manager

Manasvi Marathe has been building her clinical research experience for several years after earning her Master’s in Public Health from NYU. She studied and received her degree in dentistry, where her passion for research started. Her knowledge of ICH-GCP, regulatory affairs and protocol management provide her the foundation for her project management role in the CDCM.

View Manasvi Marathe's profile >>

Liwen Xu, PhD


Liwen Xu is an experienced senior scientist who primarily works on the gene editing platform of the CDCM pipeline. She has extensive experience in cell and molecular biology, CRISPR techniques, and lab management. 


Tyler Kashuv

Research Coordinator, Binns Program for Cord Blood Research 

Tyler Kashuv is currently one of the Clinical Research Coordinators for the Binns Program for Cord Blood Research. Prior to joining Stanford, Tyler graduated in 2021 from the University of Miami, earning a B.S. in Biochemistry and Molecular Biology, a B.S. in Physics, and a double minor in Mathematics and Chemistry. During his time at his alma mater, Tyler developed a passion for research and medicine. This motivated him to pursue research experience in immuno-oncology & autoimmune disease, to join a pancreatic cancer lab as an undergraduate researcher and investigate PDAC, tumor microenvironment, and circulating tumor cells, to work as a teaching assistant for Physics courses, and to mentor dozens of pre-medical students seeking careers in healthcare and in research. He aspires to attain an MD-PhD and pursue a career as a surgeon.

View Tyler Kashuv's profile >>

Stem Cell and Gene Therapy Clinical Trials Program

Kirstin Dougall, MBA

Director, Finance and Operations  

Kirstin Dougall leads the finance and operations of the Clinical Trials Program, including oversight of budgets, billing, staffing, and development of new protocols. She has extensive experience in clinical research operations, both as a coordinator and as a manager.


Ali Bouge, MS, RAC

Director, Regulatory Affairs and Quality Assurance 

Ms Bouge is our in house expert in regulatory affairs and quality assurance. She has managed IRBs, provided consulting advice, and is as Associate Teaching Professor in biomedical regulatory affairs at the University of Washington.

View Ali Bouge's profile >>

Laboratory for Cell and Gene Medicine

Kathryn Melsop

Director, Finance and Facility Operations

Kathryn oversees finance and facility operations at the Laboratory for Cell and Gene Medicine (LCGM) and is the key liaison to the CDCM and its investigators. Her experience at Stanford includes program management and administration of complex research centers.

View Kathryn Melsop's profile >>